AbCellera Biologics OverviewAbCellera Biologics Other Income Expense Net
Other Income/Expense Net for ABCL.
Quarterly Other Income/Expense
$7.98M
↓ 84.7% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$37.81M
↓ 75.51% YoY
Trailing 12 months ending Mar 31, 2026